THE MCMANUS GROUP for ALLERGAN INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Development of policies to advance the antimicrobial research and novel product development environment, including advancing new market incentives.
Foreign entity interest: 100% ownership by Allergan plc, Clonshaugh Business and Technology Park, Coolock, Dublin, D17 E400, Ireland.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Medicare/Medicaid MMM
Medicare payment for inpatient antibiotics.
Foreign entity interest: 100% ownership by Allergan plc, Clonshaugh Business and Technology Park, Coolock, Dublin, D17 E400, Ireland.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BARRETT THORNHILL | — |
Copyright/Patent/Trademark CPT
Patent issues related to biopharmaceuticals, including S. 1948 - A bill to abrogate the sovereign immunity of Indian tribes as a defense in inter partes review of patents.
Foreign entity interest: 100% ownership by Allergan plc, Clonshaugh Business and Technology Park, Coolock, Dublin, D17 E400, Ireland.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.